OBIO hosted 'Going Virtual for Product Development, Manufacturing & Clinical Trials' workshop on Tuesday, March 5th, which featured three industry professionals who discussed virtual operations and shared advice on how to be successful as a ‘virtual’ company.
Picking up where we left off last week, the second day of the 2019 Niagara Investment Summit (February 20th-22nd, 2019) continued on the first day’s theme: bringing together CEOs and senior executives from Canada’s most innovative health science companies with investors and strategics in beautiful Niagara-on-the-Lake.
The OBIO 2019 Niagara Investment Summit, held in historic Niagara-on-the-Lake from February 20th through 22nd, brought together CEOs and senior executives representing Canadian health science companies from Halifax to Vancouver, global investors and venture capitalists, and health science industry leaders for two panels of company presentations, one-on-one meetings, panel discussions and keynote speakers.
On February 26th, OBIO hosted Jasmin Ganie-Hobbs (Director Tech Finance, BDC) and Antonio Lopes (Global Accounts Director, EDC) who spoke about “How BDC and EDC Can Help Your Business.”
OBIO® (Ontario Bioscience Innovation Organization) is proud to announce the success of the 2019 Niagara Investment Summit on February 20-22, 2019. The 2019 Niagara Investment Summit featured over 30 of Canada’s most promising innovative health science companies and more than 30 US and global investors and VCs.
OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.
OBIO’s recent Cross Border Investing panel on January 31, 2019, hosted by Osler Hoskin & Harcourt LLP and moderated by Gail Garland (CEO, OBIO), featured David Young (CEO, Kisoji Biotechnology), Mike Cooke (CEO, AmacaThera) and Chad Bayne (Partner, Osler) answering questions on their experiences raising money for Canadian companies from international investors.
On January 24th, OBIO’s C-Suite Pub Night networking event was attended by over 50 CEOs and senior health science company executives.
On November 28th, OBIO held our 2018 Annual General Meeting at the offices of Norton Rose Fulbright. The exciting event featured Nik Nanos, our keynote speaker whose presentation Global Disruption: How to Make Decisions in an Age When Truth and Data are No Longer Enough to Persuade scanned recent global political experiences and explained the outsized influence of the margins, both on electoral outcomes as well as the impact for your company.
you are considering hiring a new graduate or intern this coming January, it is a good idea to get started now. OBIO H2BB is constantly sourcing new early career talent from top business and innovation programs and is filling roles now.
2019 Call for Applications - NOW OPEN. OBIO CAAP® is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an expansive network of health science industry experts and investors to enhance the ability of OBIO CAAP companies to secure financing.
Last week, OBIO announced the successful completion of the OBIO Canadian Health Investment Showcase in New York City. Check out this recap and photo gallery of the event.
The Ontario Bioscience Innovation Organization (OBIO®) is honoured to announce the conclusion of the successful Canadian Health Investment Showcase which took place in New York, NY, on November 5 and 6, 2018.
Candidates like these are currently interviewing for placements for this January’s H2BB cohort. Don't miss out on the best and brightest business talent!
Co-op students for January internships are already securing positions. OBIO H2BB can help connect you to top tier talent from programs with January internships including McMaster’s Master of Biomedical Discovery and Commercialization, University of Toronto’s Master of Biotechnology and McMaster’s DeGroote Co-op MBA. Students from these programs may qualify for Ontario’s Co-operative Education Tax Credit.
This week, as part of the TCI Network 2018 Global Conference, OBIO CEO Gail Garland led a session with Canadian and international experts on our domestic health cluster.
On October 3rd, OBIO hosted a CEO2CEO event attended by over 30 CEOs and senior health science company executives
In response to industry demand, OBIO is proud to announce the launch of the OBIO Job Board, its latest ‘Access to Talent’ program.
The OBIO Job Board will be hosted on the newly revamped OBIO website and will be free for all health science companies wishing to post their latest health science job openings.